Home › IGA Glomerulonephritis › Colorado › Denver
IGA Glomerulonephritis clinical trials in Denver, CO
5 studies for IGA Glomerulonephritis are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
- Jade Clinical Site, Denver
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Colorado Kidney Care Nephrology, Denver
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
RecruitingPhase 2
- Colorado Kidney Care Nephrology, Denver
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Colorado Kidney and Vascular Care, Denver
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
RecruitingPhase 2
- Clinical Research Site 330, Denver
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Orlando, FL5 studies
- Sioux City, IA4 studies
- Los Angeles, CA4 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Johns Creek, GA3 studies
- Philadelphia, PA3 studies
- Columbus, OH3 studies
- Cedar Rapids, IA3 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Multiple Myeloma27 studies
- Non-Small Cell Lung Cancer27 studies
- Colorectal Cancer23 studies
- Prostate Cancer19 studies
- Melanoma19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.